Brent Pfeiffenberger - Mar 7, 2024 Form 4/A Insider Report for Butterfly Network, Inc. (BFLY)

Role: President and CEO, Director
Signature: /s/ Douglas Carr, Attorney-in-Fact
Stock symbol: BFLY
Transactions as of: Mar 7, 2024
Transactions value $: $0
Form type: 4/A
Date filed: 5/24/2024, 05:14 PM
Date Of Original Report: Mar 11, 2024
Previous filing: Dec 6, 2023
Next filing: Dec 6, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BFLY	Common Stock						0	Mar 7, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BFLY	Stock Option (right to buy)						0	Mar 7, 2024	Common Stock			Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 4 Amendment is being filed to correct the original Form 4. The original Form 4 was filed erroneously with an incorrect Issuer. The Reporting Person has no affiliation nor does he own any shares of Butterfly Network, Inc. The Reporting Person is the President and CEO of Century Therapeutics, Inc. and a correct Form 4 has been filed.